Related Experiment Video
Updated: Jul 10, 2026
10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Tuberculosis in the Czech Republic during 2006]
J Homolka1, F Krejbich, J Holub
1I. klinika tuberkulózy a respiracních nemocí 1. LF UK a VFN, Praha. jhomolka@cesnet.cz
Casopis Lekaru Ceskych
|October 31, 2007
Summary
Tuberculosis cases declined in the Czech Republic in 2006, with low drug resistance. Future efforts should focus on active case-finding in high-risk groups to further reduce tuberculosis incidence.
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Control
Context:
- The Czech Republic observed a continued decrease in tuberculosis notification rates in 2006.
- 973 cases (9.5/100,000) of all tuberculosis types were reported, including 799 pulmonary cases.
- A significant portion of pulmonary tuberculosis cases (5.5/100,000) were definite pulmonary tuberculosis.
Purpose:
- To analyze the trends in tuberculosis notification rates and drug resistance in the Czech Republic.
- To evaluate the effectiveness of passive versus active case-finding strategies for tuberculosis detection.
- To identify future targets for tuberculosis control, including active case-finding and latent infection monitoring.
Summary:
- Tuberculosis notification rates continued to decline in the Czech Republic in 2006.
- Drug resistance was low at 7.4%, with multidrug-resistant tuberculosis (MDR-TB) at 1.4% of confirmed cases.
- Passive case-finding diagnosed the majority of tuberculosis cases (74.7%), while active case-finding identified only 11.7%.
Impact:
- The low drug resistance and effective treatment suggest a presumption of further decline in tuberculosis.
- There is a need to increase active case-finding in high-risk populations to improve tuberculosis detection rates.
- Monitoring latent tuberculosis infection is a key future strategy for comprehensive tuberculosis control.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...